EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fisetin-loaded Nanoemulsion and Fecal Microbiome Extract Enhance In Vitro Inhibition of Non-Small Cell Lung Cancer Progression

Adam Haysom-McDowell, Keshav Raj Paudel, Samir Mehndiratta, Manisha Singh, Md Zubbair Malik, Sofia Kokkinis, Prisca Deviani Pakan, Frederick E Williams, Sachin Kumar Singh, Kamal Dua, Gabriele De Rubis

Cell Biochemistry and Biophysics · 2026

DOI: 10.1007/s12013-025-01981-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, 2026. Verfasst von Adam Haysom-McDowell und 10 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, 2007, Australia. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Flavonoids, Feces. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Technology Sydney.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer (LC) remains the leading cause of cancer-related deaths worldwide, with non-small cell lung cancer (NSCLC) accounting for the majority of cases. While conventional treatments such as chemotherapy and radiotherapy are highly established, adverse effects and therapy resistance necessitate the exploration of novel therapeutic strategies. This study investigates the in vitro anti-cancer potential of the flavonoid fisetin and its nanoemulsion formulation (FNE) in NSCLC, alongside fecal microbiome extract (FME) as a potential adjunct therapy. In vitro functional assays demonstrated that while pure fisetin powder did not significantly inhibit NSCLC cell proliferation, colony formation nor cell migration, FNE and FME exhibited notable cytotoxic effects. Protein array analysis identified significant downregulation of 22 key oncogenic proteins implicated in lung cancer tumour development, epithelial-mesenchymal transition, tumour microenvironment, immunomodulation, therapy resistance, and metastasis. Importantly, the computational analysis supported these results by identifying fisetin-associated genes that correspond to the experimentally downregulated proteins. Computational in silico analysis of fisetin-associated genes identified multiple lung cancer targets including IL6, SERPINE1, PDGFA, MMP3, MST1, MET, and ENPP2. These findings highlight the enhanced therapeutic efficacy achieved through a phytoceutical-loaded nanoemulsion and microbiome-modulated anti-cancer mechanisms, with improved outcomes when combining FNE and FME treatments. The integration of phytoceuticals and microbiome research represents a promising avenue for advancing NSCLC treatment strategies and overcoming current therapeutic limitations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsFlavonoidsFecesNanoparticlesAntineoplastic AgentsHumansFlavonolsEmulsionsCell ProliferationCell Line, TumorCell Movement

Stichwörter der Autor:innen

Fecal microbriome extractFisetinNanoemulsionNon-small cell lung cancerPhytoceuticals

Substanzen

fisetinFlavonolsEmulsionsFlavonoidsAntineoplastic Agents

Autor:innen und Institutionen

  • Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, 2007, Australia.
  • Woolcock Institute of Medical Research, Macquarie University, Sydney, NSW, 2109, Australia.
  • Centre for Inflammation Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, 2007, Australia.
  • Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India.
  • NICM Health Research Institute & School of Science, Western Sydney University, Westmead, NSW, 2145, Australia.
  • Department of Biotechnology, Jaypee Institute of Information Technology (JIIT), Noida, Uttar Pradesh, India.

Förderung

  • University of Technology Sydney

Zitieren

APA

Haysom-McDowell, A., Paudel, K. R., Mehndiratta, S., Singh, M., Malik, M. Z., Kokkinis, S., Pakan, P. D., Williams, F. E., Singh, S. K., Dua, K., & De Rubis, G. (2026). Fisetin-loaded Nanoemulsion and Fecal Microbiome Extract Enhance In Vitro Inhibition of Non-Small Cell Lung Cancer Progression. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-025-01981-2

Vancouver

Haysom-McDowell A, Paudel KR, Mehndiratta S, Singh M, Malik MZ, Kokkinis S, et al. Fisetin-loaded Nanoemulsion and Fecal Microbiome Extract Enhance In Vitro Inhibition of Non-Small Cell Lung Cancer Progression. Cell Biochemistry and Biophysics. 2026. doi:10.1007/s12013-025-01981-2

BibTeX
@article{HaysomMcDowell2026,
  author = {Haysom-McDowell, Adam and Paudel, Keshav Raj and Mehndiratta, Samir and Singh, Manisha and Malik, Md Zubbair and Kokkinis, Sofia and Pakan, Prisca Deviani and Williams, Frederick E and Singh, Sachin Kumar and Dua, Kamal and De Rubis, Gabriele},
  title = {Fisetin-loaded Nanoemulsion and Fecal Microbiome Extract Enhance In Vitro Inhibition of Non-Small Cell Lung Cancer Progression},
  journal = {Cell Biochemistry and Biophysics},
  year = {2026},
  doi = {10.1007/s12013-025-01981-2}
}
Kostenlos starten →